Cervantes, Francisco <br/><br/>
Early intervention during imatinib therapy in patients with newly diagnosed chronic-phase chronic myeloid leukemia: a study of the Spanish PETHEMA group.  [electronic resource] 

 -  Haematologica  Aug 2010 
 - 1317-24 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.2009.021154  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Anemia--chemically induced<br/>Antineoplastic Agents--adverse effects<br/>Benzamides<br/>Drug Administration Schedule<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Imatinib Mesylate<br/>Leukemia, Myeloid, Chronic-Phase--drug therapy<br/>Male<br/>Middle Aged<br/>Neutropenia--chemically induced<br/>Piperazines--adverse effects<br/>Pyrimidines--adverse effects<br/>Spain<br/>Thrombocytopenia--chemically induced<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult